Open AccessScientific Rationale for Waiving Clinical Efficacy Testing of Biosimilars
Author(s) -
Sarfaraz K. Niazi
Publication year - 2022
Publication title -
drug design development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s378813
Subject(s) - biosimilar , medicine , clinical trial , mindset , clinical pharmacology , clinical efficacy , risk analysis (engineering) , pharmacology , intensive care medicine , computer science , artificial intelligence
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom